Loading organizations...
§ Private Profile · Shuangliu, Sichuan, China
Novel vaccine development and commercialization.
MAXVAX has raised $41.6M across 1 funding round.
MAXVAX has raised $41.6M in total across 1 funding round.
MAXVAX has raised $41.6M across 1 funding round. Most recently, it raised $41.6M Series C in February 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 6, 2024 | $41.6M Series C | Shenzhen Capital Group | — | Announced |
MAXVAX has raised $41.6M in total across 1 funding round.
MAXVAX's investors include Shenzhen Capital Group.